Citadel Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.1K Buy
10,700
+500
+5% +$3.31K ﹤0.01% 12313
2025
Q4
$80.1K Buy
+10,200
New +$80.3K ﹤0.01% 11792
2025
Q3
Sell
-18,100
Closed -$84.5K 14572
2025
Q2
$84.5K Sell
18,100
-9,400
-34% -$43.1K ﹤0.01% 11453
2025
Q1
$151K Buy
27,500
+14,500
+112% +$58.5K ﹤0.01% 10865
2024
Q4
$44.1K Sell
13,000
-83,500
-87% -$269K ﹤0.01% 12522
2024
Q3
$275K Buy
96,500
+8,000
+9% +$20.5K ﹤0.01% 9511
2024
Q2
$199K Buy
88,500
+22,800
+35% +$46K ﹤0.01% 9953
2024
Q1
$145K Sell
65,700
-150,200
-70% -$389K ﹤0.01% 10814
2023
Q4
$507K Sell
215,900
-37,700
-15% -$69.6K ﹤0.01% 8069
2023
Q3
$472K Sell
253,600
-69,600
-22% -$159K ﹤0.01% 8184
2023
Q2
$847K Buy
323,200
+184,100
+132% +$469K ﹤0.01% 6802
2023
Q1
$227K Sell
139,100
-52,300
-27% -$65.5K ﹤0.01% 9955
2022
Q4
$255K Buy
191,400
+15,400
+9% +$21.7K ﹤0.01% 9663
2022
Q3
$275K Sell
176,000
-50,300
-22% -$83.2K ﹤0.01% 9758
2022
Q2
$349K Buy
226,300
+21,000
+10% +$44.3K ﹤0.01% 9473
2022
Q1
$526K Sell
205,300
-138,900
-40% -$339K ﹤0.01% 9266
2021
Q4
$1.01M Buy
344,200
+11,000
+3% +$23.8K ﹤0.01% 7936
2021
Q3
$816K Sell
333,200
-36,000
-10% -$105K ﹤0.01% 8648
2021
Q2
$1.5M Buy
369,200
+223,300
+153% +$852K ﹤0.01% 7314
2021
Q1
$658K Sell
145,900
-89,600
-38% -$483K ﹤0.01% 9086
2020
Q4
$1.16M Buy
235,500
+96,700
+70% +$484K ﹤0.01% 6491
2020
Q3
$823K Buy
+138,800
New +$555K ﹤0.01% 6384
2020
Q2
Sell
-11,200
Closed -$22K 10702
2020
Q1
$22K Buy
11,200
+200
+2% +$860 ﹤0.01% 9278
2019
Q4
$78K Buy
+11,000
New +$90.8K ﹤0.01% 8640

Other funds holding XERS